Content
All Posts > Content under Upgrades and Downgrades
Flexion Price Target Raised To $25 From $19 At Benchmark
Article By:
The Fly
Read
Friday, December 27, 2019 11:16 AM EDT
Benchmark analyst Bruce Jackson raised his price target for Flexion Therapeutics to $25 from $19 after the company received FDA approval to update the product label for Zilretta for the treatment of osteoarthritis knee pain.
In this article: FLXN